Table 5.
Parameter | Experimental group |
Control group |
||
Before | After | Before | After | |
1st phalange (AS) | 13.41 ± 3.36 | 24.67 ± 6.27b,d | 11.19 ± 5.11 | 14.68 ± 5.66a |
1st phalange (HS) | 34.85 ± 4.22 | 29.28 ± 4.04a | 32.61 ± 5.04 | 27.80 ± 5.19 |
Anterior foot (AS) | 222.54 ± 22.34 | 259.24 ± 24.02b,d | 215.21 ± 23.80 | 239.07 ± 22.97a |
Anterior foot (HS) | 269.11 ± 27.88 | 235.20 ± 32.56b,d | 282.45 ± 31.87 | 257.73 ± 30.21b |
Midfoot (AS) | 60.14 ± 15.49 | 72.08 ± 8.78 | 53.65 ± 14.52 | 60.31 ± 14.75 |
Midfoot (HS) | 82.54 ± 10.97 | 77.51 ± 12.75 | 74.98 ± 13.64 | 73.64 ± 14.71 |
Medial heel (AS) | 93.13 ± 10.16 | 85.08 ± 9.81b,c | 100.44 ± 10.93 | 97.16 ± 12.31 |
Medial heel (HS) | 113.30 ± 13.01 | 97.11 ± 14.51b,c | 118.03 ± 10.86 | 110.34 ± 11.69a |
Lateral heel (AS) | 118.04 ± 11.29 | 108.55 ± 11.28b,c | 122.51 ± 9.77 | 116.38 ± 8.49a |
Lateral heel (HS) | 134.64 ± 17.12 | 119.58 ± 15.90b,c | 140.10 ± 14.48 | 130.36 ± 11.91a |
Comparison with before treatment: aP < 0.05, bP < 0.01; comparison with the control group: cP < 0.05, dP < 0.01. AS: Affected side; HS: Healthy side.